Is Moderna Stock a Buy Now?
3/2 14:05
The past three years have been fascinating for Moderna (NASDAQ: MRNA) and its shareholders. Early in the pandemic, the biotech quickly established itself as a leader in the hunt for an effective COVID-19 vaccine, a position it justified by creating and marketing one of the most s...